Executive Director, Clinical Pharmacology/Pharmacometrics
RecursionRemote Opportunity - United States; Salt Lake City, UtahRemote
46/100 · Weak. Based on age, reposts, pay, the company's hiring and ghost signals.
See the evidence behind this score.
Pro shows each part of the score, the reasons, the pay percentile and the listing history.
HirQ's ghost-risk estimate and company labels are automated opinions based on what we observe on employers' public job boards: how long a listing has been open, whether it was re-listed, wording in the description, and how often roles on that board close. They are not statements about an employer's intent, and a high-risk listing can still be a real opening. Figures are as of the date shown. How we measure
“Boston”
Employer-posted ranges for Science & Research roles in MA in the last 12 months (377 postings).
This job: No pay listed
From Proxima's careers page, checked Nov 21
Proxima (formerly VantAI) is a frontier AI and data generation company discovering the next generation of proximity therapeutics by making protein interactions programmable. Our platform brings together foundation-model machine learning, a scalable data generation engine, and a partnership track record exceeding $5B in collaborations across the world’s leading biopharma and tech organizations. We’ve recently closed an oversubscribed seed round with an elite group of VCs including DCVC, NVIDIA’s NVentures, AIX, Yosemite among others.
Neo-1 is our all-atom foundation model that combines state-of-the-art structure prediction and molecular generation in a single system. Neo-1 enables rapid exploration of chemical and structural space for high value, previously intractable targets, and in particular unlocks small molecule proximity therapeutics like molecular glues with AI for the first time.
In parallel, we are developing an advanced structural interactomics platform built on proprietary XLMS technology and a lab equipped with next-generation mass spectrometry instrumentation. This platform produces proteome-scale maps of protein interactions and helps identify small molecules that modulate proximity. Together with Neo-1, it creates an integrated system capable of co-folding protein complexes while generating candidate small molecules to influence those interactions.
Proximity-based therapeutics represent one of most promising frontiers in modern drug discovery with the potential to treat previously intractable diseases and target ‘undruggable’ proteins. We’re building the tech and the team to make that happen. . Come join us!
We're looking for a Biologist, Cellular Pharmacology to design and execute cell-based assays that validate targets and computationally driven hits across our proximity drug discovery programs. You'll work across the full discovery arc, from target validation through hit ID, hit-to-lead, and lead optimization, owning the cellular pharmacology data that drives internal pipeline decisions and external partner deliverables.
This is a hands-on role: you'll run select assays in-house, manage CROs, and work closely with our structural proteomics data generation platform and computational teams, helping shape how our platform is applied to proximity-based drug discovery.
This is a high-impact role in a small, fast-moving team where your experimental results directly shape the direction of programs.
Same role or field, nearby or remote, ranked by HirQ score.
RecursionRemote Opportunity - United States; Salt Lake City, UtahRemote
OpenAISan FranciscoRemote
OpenAISan FranciscoRemote
Ramp (Ashby)Remote (US)Remote
SystemNew York City, RemoteRemote
HUMANUnited StatesRemote
Principal Biologist
No pay listed · HirQ 46